Related references
Note: Only part of the references are listed.β-Adrenergic receptor expression in vascular tumors
Karen M. Chisholm et al.
MODERN PATHOLOGY (2012)
Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action
C. H. Storch et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells.
Shoshana Greenberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Functional Expression of β2 Adrenergic Receptors Responsible for Protection Against Oxidative Stress Through Promotion of Glutathione Synthesis After Nrf2 Upregulation in Undifferentiated Mesenchymal C3H10T1/2 Stem Cells
Yoshifumi Takahata et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion
Borhane Annabi et al.
PHARMACOLOGICAL RESEARCH (2009)
Propranolol for severe hemangiomas of infancy
Christine Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evaluating systemic prednisone therapy for proliferating haemangioma in infancy
Jochen Roessler et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Heterozygous α2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction
Ralf Gilsbach et al.
CARDIOVASCULAR RESEARCH (2007)
Haemangiomas and vascular malformations of the limb in children
Mairi Steven et al.
PEDIATRIC SURGERY INTERNATIONAL (2007)
GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas
PE North et al.
HUMAN PATHOLOGY (2000)
Share Paper
